Sleep Apnea and Atrial Fibrillation: How They’re Connected

Research points to a strong link between obstructive sleep apnea and atrial fibrillation. Learn why treating both conditions is crucial.

7:00 AM

Author | Jane Racey Gleeson

After diagnosing a patient with atrial fibrillation, a doctor might recommend testing for obstructive sleep apnea, or OSA.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

The reason: "Obstructive sleep apnea is highly associated with atrial fibrillation," says Krit Jongnarangsin, M.D., an electrophysiologist at the University of Michigan Frankel Cardiovascular Center.

Atrial fibrillation, or Afib, affects an estimated 6 million Americans. It is an arrhythmia characterized by a quivering or irregular heartbeat that can lead to stroke and other heart-related complications.

Although atrial fibrillation can have a range of causes — age, heart disease and hypertension among them — research reveals a strong link between Afib and OSA.

About half of Afib patients have OSA.

People with OSA experience a blockage in the airway, or restricted breathing, for 10 seconds or longer during sleep. The condition can range from mild to severe, based in part on the number of times each hour that a patient stops breathing.

Sleep apnea risk factors

Jongnarangsin recommends that patients diagnosed with Afib be assessed for the following risk factors associated with OSA:

  • Excess weight

  • Narrowed airway

  • Chronic nasal congestion

  • High blood pressure

  • Smoking and alcohol use

  • Age (OSA is more common after age 40)

  • Gender (OSA is more common in men)

  • Family history of OSA

Further examination is needed if risk factors are found.

"We refer them to a sleep specialist, who will screen the patient and, if OSA is diagnosed, recommend continuous positive airway pressure (CPAP) treatment," Jongnarangsin says.

Treating both conditions

CPAP treatment involves wearing a mask during sleep. The mask conducts pressurized air through the nose, or through the nose and mouth, to the throat. The added pressure in the throat then keeps it from collapsing during sleep to enable normal breathing.

SEE ALSO: How Chronic Snoring Can Cause Heart Disease

A patient's Afib is treated in conjunction with CPAP treatment, says Jongnarangsin.

The treatment for Afib is often catheter ablation, a minimally invasive technique in which a catheter is threaded through the blood vessels and into the left atrium of the heart, where radiofrequency or cryo energy is applied to the heart muscle to cauterize the "short circuits" in the heart's electrical system that are generating the Afib.

That method is most effective when combined with CPAP adherence.

"Ablation is more successful in patients who are using CPAP for their OSA," Jongnarangsin says. "If a patient is diagnosed with OSA but not treated for it, the Afib recurrence following ablation is much higher than in patients without obstructive sleep apnea."

That's why it's crucial for Afib patients and their health care providers to discuss the possibility of OSA — and, if detected, to treat both conditions.


More Articles About:

Heart Health Atrial fibrillation (Afib) Sleep Apnea Cardiovascular: Diseases & Conditions
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Boy in white t-shirt, just chin showing, with hands holding a stethoscope on his chest.
Health Lab

Distance, insurance, social factors may hinder access to lifesaving heart monitoring for children

New research suggests that social, economic and geographic factors may influence whether patients who undergo the Fontan surgery for complex congenital heart disease receive the recommended lifelong cardiac monitoring.
A smartphone displaying a red heart with a white EKG line on its screen, set against a teal background.
Health Lab

Mobile health app improves heart failure medication use, dosing after hospitalization

A U-M-led trial found a mobile app improved use and dosing of recommended heart failure medications during the 90 days following a hospital discharge.
Three people in a bar watch a television displaying a sports logo and a person smiling. Shelves with bottles and a counter with glasses are visible.
Health Lab

Jalen Hurts’ blood clot diagnosis: doctors answer common questions

After Jalen Hurts’ blood clot diagnosis, Michigan Medicine experts explain clot risks, treatment and returning safely to sports.
A pill bottle is open and pills are placed onto a hand
Health Lab

Could a diabetes medication be the next wonder drug?

Researchers identified how sotagliflozin may reduce heart attack and stroke risk, potentially offering benefits beyond diabetes care
Two people in medical scrubs are in a blurred hospital setting. In the foreground, hands are holding a digital tablet.
Health Lab

Digital alerts support timely treatment decisions of critically ill cardiac patients

Well-designed alerts for critically ill cardiac patients can change what happens at the bedside, according to new Michigan Medicine research.
Minding memory above a microphone on a blue background
Minding Memory

Is the United States Lagging Behind Europe in Memory Improvement?

In this episode, Lauren & Matt speak with Neil Mehta, PhD who is the associate dean for research and a professor in the Department of Epidemiology at the University of Texas Medical Branch in Galveston. Dr. Mehta’s research focuses on US life expectancy trends, the effects of obesity on disability and mortality, the sources of socioeconomic status disparities in mortality, and patterns of health in the United States and Europe. Dr. Mehta talks about a recent manuscript from the NIA-funded TRENDS study called “Trends in Memory Function and Memory Impairment Among Older Adults in the United States and Europe, 1996 to 2018.”, which looks at data from several sources to compare trends in memory function across 13 different countries.